Clinical Trial Update: A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial of DS-5565 in Chinese patients with diabetic peripheral neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain

Drugs mentioned

• DS-5565 (DS-5565)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 3 | Status: COMPLETED